<DOC>
	<DOCNO>NCT01323829</DOCNO>
	<brief_summary>This prospective , pilot , longitudinal study evaluate use EMG guidance Botox A injection chronic pelvic pain HTPFD . The objective study determine efficacy inject botulinum toxin type A pelvic floor muscle high tone . Patients diagnose high tone pelvic floor muscle dysfunction fail treatment eligible participate study . Study related procedure include perineometry reading . Patients require complete 7 questionnaire study . These include visual analog scale ( scale 0-10 ) pain ( VAS ) , O'Leary-Sant urinary symptom problem questionnaire ( ICSI/ICPI ) , Pelvic Floor Distress Inventory 20 ( PFDI-20 ) , Female Sexual Distress Scale ( FSDS ) , Global Response Assessment Scale SF-12 quality life scale . The use EMG guidance experimental part study . We perform EMG Needle test order pin-point best location patient Botox injection . This prospective , pilot , longitudinal study evaluate effect Botox A injection chronic pelvic pain HTPFD .</brief_summary>
	<brief_title>EMG Guided Botulinum Toxin Type A Injections Refractory High Tone Pelvic Floor Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Participant must diagnose High Tone Pelvic Floor Dysfunction ( HTPMFD ) . Participant must try fail least one conventional mode therapy HTPMFD . Participant must female least 18 year age . Participant must give write informed consent participate study . Participant must able make decision . Participant must undergo another procedure time BTX A injection . Participant male . Patient history past BTX A use Patient pelvic organ prolapse repair Participant pregnant intend get pregnant study period breastfeed . Participant unwilling unable ( long distance office ) followup . Participant neuromodulator device implant . Participant known bleed disorder anticoagulation . Participant known hypersensitivity BTX A . Participant preexist neuromuscular disorder amytrophic lateral sclerosis , motor neuropathy , myasthenia gravis LambertEaton syndrome . Participant skin infection perineum site injection .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>High Tone Pelvic Floor Dysfunction</keyword>
	<keyword>Botulinum toxin type A</keyword>
	<keyword>EMG</keyword>
</DOC>